Ubong Silas
Ubong Silas publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine, on topics such as Heart Failure Treatment and Management, Lung Cancer Treatments and Mutations and Health Systems, Economic Evaluations, Quality of Life.
- World rank
- #4,113,219 of 7,710,434 ranked researchers
- Rank in United States
- #1,115,608 of 1,627,098
- Works
- 28
- Citations
- 66
- Citations per work
- 2.4
What does Ubong Silas research?
Ubong Silas's work is mostly in Medicine (47%), Economics, Econometrics and Finance (10%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1347.0%
- Medicine1347.0%
- Everything else1138.3%
- Social Sciences310.3%
- Life Sciences14.4%
- 1Cardiology and Cardiovascular Medicine13% of their works
- 2Surgery13% of their works
- 3Pulmonary and Respiratory Medicine12% of their works
- 4Economics and Econometrics10% of their works
- 5Neurology9% of their works
- 6Cancer Research4% of their works
Research topics
- Heart Failure Treatment and Management
- Lung Cancer Treatments and Mutations
- Health Systems, Economic Evaluations, Quality of Life
- Cancer Genomics and Diagnostics
- Parkinson's Disease Mechanisms and Treatments
- Mechanical Circulatory Support Devices
- Healthcare Systems and Practices
- Airway Management and Intubation Techniques
Which keywords describe Ubong Silas's research?
The keywords of their largest research topics: Targeted Therapy, Heart Failure, ALK Inhibitors, Cost-effectiveness Analysis, Diagnosis, EGFR Mutations, Guidelines and Quality of Life.
- Tracheal Intubation
- Left Ventricular Assist Device
- Extracorporeal Membrane Oxygenation
- a-Synuclein
- Mutational Signatures
- Quality of Life
- EGFR Mutations
- Cost-effectiveness Analysis
- Heart Failure
- Targeted Therapy
- ALK Inhibitors
- Diagnosis
- Guidelines
- Cancer Genomics
- Parkinson's Disease
- Difficult Airway Society
- Healthcare Policy
- Public Health
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Targeted Therapy72 topics
- Heart Failure62 topics
- ALK Inhibitors41 topic
- Cost-effectiveness Analysis41 topic
- Diagnosis41 topic
- EGFR Mutations41 topic
- Guidelines41 topic
- Quality of Life41 topic
- Cancer Genomics31 topic
- Mutational Signatures31 topic
- Parkinson's Disease31 topic
- a-Synuclein31 topic
- Difficult Airway Society21 topic
- Extracorporeal Membrane Oxygenation21 topic
- Healthcare Policy21 topic
- Left Ventricular Assist Device21 topic
- Public Health21 topic
- Tracheal Intubation21 topic
Where does Ubong Silas work?
Ubong Silas's main affiliation in the publication record is Elmhurst College, United States.
How many publications and citations does Ubong Silas have?
OpenAlex counts 28 works and 66 citations for Ubong Silas, an h-index of 4, ranking #4,113,219 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ubong Silas. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.